41 – 59 of 59
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2015
-
Mark
Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube
(
- Contribution to journal › Article
-
Mark
Acute leukemias of ambiguous origin
(
- Contribution to journal › Scientific review
-
Mark
Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Evolving Therapeutic Options for Polycythemia Vera : Perspectives of the Canadian Myeloproliferative Neoplasms Group
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
The role of diagnostic tissue in research
(
- Contribution to journal › Article
-
Mark
Dendritic Cells in Bone Marrow at Diagnosis and after Chemotherapy in Adult Patients with Acute Myeloid Leukaemia
(
- Contribution to journal › Article
-
Mark
ETV6/FLT3 fusion in a mixed-phenotype acute leukemia arising in lymph nodes in a patient with myeloproliferative neoplasm with eosinophilia
(
- Contribution to journal › Article
-
Mark
Amplification of 2p as a genomic marker for transformation in lymphoma
(
- Contribution to journal › Article
-
Mark
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F
(
- Contribution to journal › Article
-
Mark
Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas
(
- Contribution to journal › Article
-
Mark
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
(
- Contribution to journal › Article
- 2011
-
Mark
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
(
- Contribution to journal › Article
-
Mark
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
(
- Contribution to journal › Article
- 2010
-
Mark
Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006
(
- Contribution to journal › Article
-
Mark
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
(
- Contribution to journal › Article
- 2009
-
Mark
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2008
-
Mark
The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma : correlation to overall survival
(
- Contribution to journal › Article
-
Mark
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following Myelodysplastic syndrome
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »